Article
Inspection Guidance Intelligence — FDA Draft Guidance Response Analysis
FDA's rewritten Preapproval Inspection compliance program — Compliance Program 7346.832, revised June 29, 2026 and effective today, August 10, 2026 — replaces the old checklist approach to PAIs…
XGene Articles & Analysis
Evidence-led analysis for decisions that matter.
Senior-authored regulatory, CMC, GMP, quality, and inspection analysis designed for practical use—not passive reading.
01SignalSource evidence
02InterpretTechnical judgment
03ApplyDecision pathway
Publication library
Keep moving from evidence to decision.
Article
Inspection Guidance Intelligence — FDA Draft Guidance Response Analysis
FDA's rewritten Preapproval Inspection compliance program — Compliance Program 7346.832, revised June 29, 2026 and effective today, August 10, 2026 — replaces the old checklist approach to PAIs…
Article
LNP Stability: 3 Degradation Pathways and the Real Shelf-Life Strategy
Lipid nanoparticles are thermodynamically metastable systems. They do not exist at equilibrium — they are kinetically trapped structures whose continued integrity depends on an ongoing balance of steric…
Article
Microbiological Data Integrity — The Lab Controls Blind Spot
Data integrity enforcement in pharmaceutical manufacturing has focused overwhelmingly on analytical chemistry laboratories — HPLC systems, balances, LIMS — while the microbiological laboratory, with its unique combination of…
Article
LNP Specifications: Acceptance Criteria for a Modality Without Full Precedent
Specifications for a lipid nanoparticle drug product are not borrowed from liposome specifications, small molecule specifications, or monoclonal antibody specifications. They are built from first principles — from…
Article
Hybrid Systems Compliance — The 21 CFR Part 11 Gap Most Teams Miss
A hybrid system — one where electronic records are supplemented by paper records, or where GMP activities are recorded in both an electronic system and a paper logbook…
Article
LNP Formulation Development Under ICH Q8: QTPP, CQA, Design Space
Most LNP CMC packages apply ICH Q8 as a formatting exercise rather than a design discipline. The QTPP table is present. The CQA list is populated. And then…
Article
FDA Computer Software Assurance 2022 — What CMC Teams Must Change Now
FDA's 2022 Computer Software Assurance guidance is not a minor update to the IQ/OQ/PQ validation framework — it is a conceptual redesign of how pharmaceutical companies should approach…
Article
Measuring What Matters: Analytical Control Strategy for a 4-Component Nanosystem
Every analytical challenge in LNP characterization flows from a single structural reality: you are measuring a four-component nanoparticle system whose identity, purity, and activity emerge from the precise…
Article
Cleaning Validation — Risk-Based Approach That Survives Pre-Approval Inspection
Cleaning validation is one of the most frequently cited deficiency areas in FDA pre-approval inspections — not because companies have not validated their cleaning processes, but because the…
Article
Microfluidic Mixing: The Process Parameters That Define Your Drug Product
There are two moments in LNP manufacturing where the drug product is made. The one that actually determines the physical attributes of the particles you will release into…
Article
Continued Process Verification Stage 3 — Building the CPV Program FDA Wants
Most pharmaceutical manufacturers have a process validation Stage 3 Continued Process Verification program on paper — and most of those programs are generating data that no one is…
Article
Drug Substance Scale-Up CMC — From Kilogram Lab to Metric Ton Commercial: The Process Validation Strategy
Scale-up from kilogram to metric-ton synthesis is not a linear amplification. It is a process re-development exercise governed by physical chemistry — heat transfer coefficients that drop by…
Read with purpose
Every analysis should make the next move clearer.
- 01ReadUnderstand the technical argument.
- 02TraceFollow evidence and regulatory context.
- 03CompareExplore related XGene intelligence.
- 04ActConnect the issue to a practical pathway.